Nalaganje...
(131)I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma
Radioimmunotherapy (RIT) options for T-cell non-Hodgkin lymphomas (T-NHLs) are limited. We evaluated anti-CD45-RIT in human (h) and murine (m) T-NHL. CD45 was highly expressed on hT-NHL patient samples (median, 2.3 × 10(5) antigen-binding capacity units/cell) and hT-NHL cell lines (3.4 × 10(5) CD45...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2700326/ https://ncbi.nlm.nih.gov/pubmed/19332764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-205476 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|